List view / Grid view
11 April 2018 | By European Pharmaceutical Review
Scientists report that by combining a robotic arm and mass spectrometry can potentially open up new branches of pharmaceutics...
29 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Nitroproston is a novel prostaglandin-based compound with potential application in obstructive respiratory diseases...
26 March 2018 | By European Pharmaceutical Review
Brazilian researchers combine mass spectrometry, 2-D liquid chromatography and ion mobility to identify over 10,000 proteins in brain cells possibly involved in schizophrenia.
22 March 2018 | By European Pharmaceutical Review
Researchers at Vanderbilt University Medical Center have used an integrated imaging approach to probe an invasive Staphylococcus aureus (‘staph’) infection in a mouse model, revealing new insights about staph infections that can be broadly applied to other diseases.
1 March 2018 | By Waters
Waters Corporation (NYSE:WAT) today introduced BioResolve™ RP mAb Polyphenyl 450 angstrom 2.7 micron solid core Columns intended for the reversed-phase analysis of intact or sub-unit-digested monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs) using LC-UV and LC-MS...
1 March 2018 | By European Pharmaceutical Review
This In-Depth Focus looks at the benefits of mass spectrometry for the characterisation of protein higher order structure and for stability testing.
27 February 2018 | By European Pharmaceutical Review
In this issue: DNA microarray for detecting, identifying and determining antimicrobial-resistant bacteria; the advantages of single-use technology and a framework for an implementation strategy; risk management when designing chemical safety assessments for pharmaceutical packaging systems.
12 February 2018 | By METTLER TOLEDO
Mass spectrometry is an extremely sensitive method for the detection and identification of traces of gaseous substances. The technique can quantify atoms or molecules and provide chemical and structural information (functional groups and side chains) on the compounds analysed...
5 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Scientists have developed and validated a blood test for Alzheimer’s disease, with the potential to massively ramp up the pace of Alzheimer’s disease drug trials...
5 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers have systematically analysed and quantified the interactions of all proteins with metabolites on the level of the whole proteome...
4 January 2018 | By Johan Devenyns, Johan Devenyns - PharmaFluidics
Much rests on the further development of bioanalytical technologies which allow the highest level of sensitivity on small samples, and robust, high reproducibility across large populations. Johan Devenyns, CEO PharmaFluidics, explains further...
4 January 2018 | By Dr Lynn Murdoch - Wickham Laboratories
When thinking about the future of the pharmaceutical sector, it can be difficult to pinpoint a specific focus as there are a wide range of challenges that come into consideration across all stages of development and manufacturing. Dr Lynne Murdoch, Business Manager – Microbiology, Wickham Laboratories, considers some key points....
13 December 2017 | By Waters
Method transfer or method scaling across different instrument platforms can be affected by both dwell volume and extra-column dispersion...
6 November 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers have developed a new drug screening technique that could lead to the rapid and accurate identification of drugs...
Send this to a friend
Follow: